| Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association LB Morgenstern, JC Hemphill III, C Anderson, K Becker, JP Broderick, ... Stroke 41 (9), 2108-2129, 2010 | 1876 | 2010 |
| Closure of patent foramen ovale versus medical therapy after cryptogenic stroke JD Carroll, JL Saver, DE Thaler, RW Smalling, S Berry, LA MacDonald, ... New England Journal of Medicine 368 (12), 1092-1100, 2013 | 1186 | 2013 |
| 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert … GF Tomaselli, KW Mahaffey, A Cuker, PP Dobesh, JU Doherty, ... Journal of the American College of Cardiology 70 (24), 3042-3067, 2017 | 698 | 2017 |
| Carotid artery diameter in men and women and the relation to body and neck size J Krejza, M Arkuszewski, SE Kasner, J Weigele, A Ustymowicz, RW Hurst, ... Stroke 37 (4), 1103-1105, 2006 | 563 | 2006 |
| Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm:[RETIRED] Report of the Quality Standards Subcommittee of the American Academy of … SR Messe, IE Silverman, JR Kizer, S Homma, C Zahn, G Gronseth, ... Neurology 62 (7), 1042-1050, 2004 | 394 | 2004 |
| Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines–stroke hospitals LH Schwamm, SF Ali, MJ Reeves, EE Smith, JL Saver, S Messe, DL Bhatt, ... Circulation: Cardiovascular Quality and Outcomes 6 (5), 543-549, 2013 | 372 | 2013 |
| Hematoma growth in oral anticoagulant related intracerebral hemorrhage B Cucchiara, S Messe, L Sansing, S Kasner, P Lyden Stroke 39 (11), 2993-2996, 2008 | 293 | 2008 |
| 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous … DJ Kumbhani, CP Cannon, CJ Beavers, DL Bhatt, A Cuker, TJ Gluckman, ... Journal of the American College of Cardiology 77 (5), 629-658, 2021 | 235 | 2021 |
| Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry SR Messé, P Khatri, MJ Reeves, EE Smith, JL Saver, DL Bhatt, ... Neurology 87 (15), 1565-1574, 2016 | 233 | 2016 |
| Stroke after aortic valve surgery: results from a prospective cohort SR Messé, MA Acker, SE Kasner, M Fanning, T Giovannetti, SJ Ratcliffe, ... Circulation 129 (22), 2253-2261, 2014 | 233 | 2014 |
| Prophylactic antiepileptic drug use is associated with poor outcome following ICH SR Messé, LH Sansing, BL Cucchiara, ST Herman, PD Lyden, SE Kasner, ... Neurocritical care 11, 38-44, 2009 | 227 | 2009 |
| Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial M Selim, LD Foster, CS Moy, G Xi, MD Hill, LB Morgenstern, ... The Lancet Neurology 18 (5), 428-438, 2019 | 226 | 2019 |
| Cerebral embolic protection during transcatheter aortic-valve replacement SR Kapadia, R Makkar, M Leon, M Abdel-Wahab, T Waggoner, ... New England Journal of Medicine 387 (14), 1253-1263, 2022 | 212 | 2022 |
| Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study MK Tamura, D Xie, K Yaffe, DL Cohen, V Teal, SE Kasner, SR Messé, ... Clinical journal of the American Society of Nephrology 6 (2), 248-256, 2011 | 205 | 2011 |
| Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale–associated stroke AY Elgendy, JL Saver, Z Amin, KD Boudoulas, JD Carroll, IY Elgendy, ... JAMA neurology 77 (7), 878-886, 2020 | 199 | 2020 |
| Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the Guideline Subcommittee of the American Academy of Neurology SR Messé, GS Gronseth, DM Kent, JR Kizer, S Homma, L Rosterman, ... Neurology 94 (20), 876-885, 2020 | 199 | 2020 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 195 | 2018 |
| Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH LH Sansing, SR Messe, BL Cucchiara, SN Cohen, PD Lyden, SE Kasner Neurology 72 (16), 1397-1402, 2009 | 191 | 2009 |
| Patent foramen ovale S Homma, SR Messé, T Rundek, YP Sun, J Franke, K Davidson, H Sievert, ... Nature reviews Disease primers 2 (1), 1-16, 2016 | 190 | 2016 |
| Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? BL Cucchiara, SR Messe, RA Taylor, J Pacelli, D Maus, Q Shah, ... Stroke 37 (7), 1710-1714, 2006 | 182 | 2006 |